Markets:

Overview

News

Currencies

International

Treasuries

iShares Russell 2000 ETF (NY:IWM)

263.33 UNCHANGED

Streaming Delayed Price Updated: 8:00 PM EST, Feb 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Terawulf Stock Is Up 10% But Retail Still Sees More Than 250% Upside: Here’s Why ↗

February 24, 2026

Analysts expect the company to post higher fourth quarter revenue than the year-ago quarter, as per data from fiscal.ai.

Via Stocktwits

Topics Artificial Intelligence

HighMark Wealth Management Buys 158,855 Shares of Axogen Stock ↗

February 24, 2026

This healthcare firm delivers surgical solutions for peripheral nerve repair, targeting specialized surgeons across U.S. and global markets.

Via The Motley Fool

Topics Regulatory Compliance

CIFR Stock Is Gaining Retail Attention After Earnings Despite Revenue Miss – Here’s What Investors Are Watching ↗

February 24, 2026

Cipher’s fourth-quarter revenue came in at $60 million, significantly below the consensus estimates of $85.7 million, according to Fiscal.ai data.

Via Stocktwits

Topics Bonds

Small Caps Hold Up As Breadth Takes A Breather ↗

February 20, 2026

Via Chartmill

Breadth Improves, But the Weekly Picture Still Needs Repair ↗

February 19, 2026

Via Chartmill

Breadth Stalls Near Resistance as Mega-Caps Cool Off ↗

February 18, 2026

Via Chartmill

Breadth Stabilizes After Violent Reversal ↗

February 17, 2026

Via Chartmill

Breadth Takes a Hit as Sellers Return in Force ↗

February 13, 2026

Via Chartmill

Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock ↗

February 23, 2026

TD Cowen analyst Joseph Thome’s new price target represents a potential upside of about 23% from AXSM’s current trading levels.

Via Stocktwits

Topics Artificial Intelligence

Bitcoin Sale Is Not A ‘Concern,’ No Plans To Stop Mining, Says Bitdeer – BTDR Stock Slips Overnight ↗

February 23, 2026

Bitdeer said on Monday that it plans to keep mining Bitcoin and anticipates that its hash rate will continue to grow.

Via Stocktwits

Topics Artificial Intelligence Bankruptcy Earnings

SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗

February 20, 2026

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).

Via Stocktwits

Topics Intellectual Property Lawsuit

VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug ↗

February 20, 2026

This is the second Vanda drug to be approved in the span of a few months, after the approval of Nereus in December.

Via Stocktwits

Breadth Rebound Holds - But Leadership Still Hesitates ↗

February 12, 2026

Via Chartmill

Breadth Cools Off, Uptrend Still Intact ↗

February 11, 2026

Via Chartmill

Breadth Holds Up After Friday’s Surge, But Momentum Cools ↗

February 10, 2026

Via Chartmill

ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗

February 20, 2026

Analysts at H.C. Wainwright hiked their price target for Ardelyx shares to $18 from $10.

Via Stocktwits

Topics Earnings Intellectual Property

ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries ↗

February 19, 2026

The company also announced the establishment of an Irish subsidiary in Dublin to support its distribution and commercialization strategy across Europe.

Via Stocktwits

LMND Stock Soars Pre-Market: Lemonade Extends Premium Growth Streak To Ninth Consecutive Quarter ↗

February 19, 2026

Lemonade reported a 31% year-on-year growth in In Force Premium to $1.24 billion in the fourth quarter.

Via Stocktwits

Topics Government

HRMY Stock Rises On Fresh FDA Approval For Wakix Tablets In Children But Wall Street Eyes Further Rally ↗

February 17, 2026

The FDA has approved Harmony’s Wakix tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy.

Via Stocktwits

Why Is TRIP Stock Rallying Today? ↗

February 17, 2026

Starboard said that it believes that Tripadvisor should be formally exploring a sale of the entire company, in one or multiple transactions.

Via Stocktwits

Wall Street Pauses for Presidents Day as Record-Breaking Dow Faces Tech Sector Headwinds

February 16, 2026

NEW YORK — The floor of the New York Stock Exchange (NYSE: ICE) sits silent today, February 16, 2026, as the U.S. financial markets observe the Presidents Day holiday. While the closure provides a...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return ↗

February 16, 2026

Learn options trading inside a system that values evidence, structure, and defined risk. A real member explains the difference.

Via InvestorPlace

Blueshift Dumps 34,000 CROX Shares Worth $2.9 Million ↗

February 14, 2026

Crocs designs and markets casual footwear and accessories for a global customer base, leveraging both retail and e-commerce channels.

Via The Motley Fool

Topics Regulatory Compliance

VOO Has Delivered Higher Returns, But IWM Provides Broad Small Cap Exposure ↗

February 14, 2026

Explore how IWM’s broader sector mix and unique small-cap focus set it apart from VOO’s concentrated large-cap approach.

Via The Motley Fool

Topics ETFs

Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns ↗

February 13, 2026

The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin.

Via Stocktwits

NVCR Rallies On FDA Approval For Cancer Treatment Device, Analyst Still Sees 275% Potential Upside ↗

February 12, 2026

H.C. Wainwright raised the firm's price target on Novocure to $47 from $39 and kept a ‘Buy’ rating on the shares after the company announced FDA approval of Optune Pax.

Via Stocktwits

Topics Government

ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff ↗

February 12, 2026

Randy Teel has been appointed as President, CEO, as well as a member of the Company’s Board of Directors, effective immediately.

Via Stocktwits

Upstart Stock Rallies 7% After-Hours Today — Who Is The New CEO? ↗

February 10, 2026

Upstart also reported total revenue of $296 million in its fourth quarter, a 35% jump from the year-ago quarter.

Via Stocktwits

Why Did RGNX Shares Plummet 19% After-Hours Today? ↗

February 09, 2026

REGENXBIO said on Monday that the U.S. Food and Drug Administration (FDA) denied approval for its gene therapy in treating Hunter syndrome, outlining several reasons for the denial.

Via Stocktwits

Upwork Stock Plummets 23% After-Hours Today – Here’s Why ↗

February 09, 2026

The company said it expects adjusted diluted EPS in the range of $0.26 to $0.28 for the first quarter of 2026, below analysts’ estimates of $0.32 per share, according to data from Fiscal.ai.

Via Stocktwits

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.